Contraception Change After Migraine with Aura

Clinical Scenario

Ruth Darby, 41, calls following an A&E visit last week for migraine with visual aura (zigzag lines followed by severe headache). A&E stopped her Microgynon 30 (combined oral contraceptive pill) and advised her to see her GP for alternative contraception. Ruth is frustrated — she has been on Microgynon for years without problems and does not understand why it has been stopped. She wants it restarted.

What This Case Tests

Applying UKMEC (UK Medical Eligibility Criteria) for contraception; explaining why combined hormonal contraception is absolutely contraindicated with migraine with aura (UKMEC 4); communicating stroke risk in accessible language; presenting progestogen-only and non-hormonal alternatives; managing frustration when a familiar medication is permanently withdrawn.

Common Mistakes Trainees Make

The three most common mistakes are: restarting the combined pill because the patient is frustrated and has only had one episode (migraine with aura is a permanent UKMEC 4 contraindication regardless of frequency), not knowing the UKMEC criteria well enough to explain why the contraindication exists, and failing to present alternative contraceptive options enthusiastically — Ruth needs to feel that the alternatives are good options, not inferior substitutes.

The Consultation Challenge

Ruth is frustrated and confused. She has taken Microgynon successfully for years, and suddenly a single migraine episode means she can never use it again. From her perspective, A&E has overreacted. Your task is to validate her frustration while clearly explaining why this contraindication is absolute and cannot be negotiated.

Start by acknowledging her frustration: "I understand this is annoying — you've been on this pill for years without any problems, and now you're being told you can't take it. Let me explain why this matters, because it's actually about keeping you safe."

Explain the mechanism clearly. Combined hormonal contraception increases the risk of ischaemic stroke by 2-4 fold. Migraine with aura independently doubles stroke risk. When combined, the effect is multiplicative — not additive. At 41, Ruth's baseline vascular risk is already increasing with age. The combination of CHC + migraine with aura + age creates an unacceptable stroke risk. This is classified as UKMEC Category 4 — an absolute contraindication with no exceptions.

Crucially, this is a permanent restriction. Even if Ruth never has another migraine with aura, she cannot return to combined hormonal contraception. A trainee who says "we'll review it if you don't get another migraine" is clinically wrong.

Now pivot enthusiastically to alternatives. The progestogen-only pill (desogestrel — Cerazette/Cerelle) is an easy switch with similar convenience. The hormonal IUS (Mirena) offers excellent contraception for up to 5 years with lighter periods. The copper IUD is hormone-free and lasts up to 10 years. The progestogen-only implant (Nexplanon) lasts 3 years. The injection (Depo-Provera) is an option but carries bone density considerations at 41. All progestogen-only methods are UKMEC 1 (no restriction) with migraine with aura.

Ruth may also have concerns about the migraine itself. Offer reassurance that the aura episode, while frightening, does not indicate a serious neurological condition. Advise on migraine triggers (stress, sleep deprivation, caffeine — all mentioned in her history) and that triptans can be used for future episodes.

Time check: Spend the first 3 minutes validating Ruth's frustration and understanding her concerns. By minute 6, explain the stroke risk clearly with the UKMEC reasoning. Use minutes 7-10 for presenting contraceptive alternatives positively. Reserve the final 2 minutes for migraine management and follow-up.

How Examiners Mark This Case

Data Gathering and Diagnosis: Examiners assess whether you confirm the migraine with aura diagnosis (visual symptoms preceding the headache — zigzag lines, scintillations, visual field loss — are characteristic). They look for whether you distinguish migraine with aura from migraine without aura (which is UKMEC 2, not 4, for CHC) and screen for other cardiovascular risk factors (smoking, BMI, family history, blood pressure). Taking a brief headache history to confirm the A&E diagnosis demonstrates thoroughness.

Clinical Management and Medical Complexity: Heavily weighted. Examiners expect accurate UKMEC Category 4 knowledge — that this is permanent and absolute, not subject to review. They look for a range of alternative contraceptive options presented with clinical detail (mechanism, efficacy, side effects), knowledge of which methods are UKMEC 1 versus restricted, and practical prescribing advice for the chosen method. A trainee who is vague about alternatives or who only mentions one option will score poorly.

Relating to Others: Examiners assess whether you validate Ruth's frustration before explaining the reasoning, whether you communicate the stroke risk in accessible language (avoiding medical jargon), and whether Ruth leaves feeling that the alternatives are genuine good options rather than second-best compromises. The consultation should feel empowering — Ruth is gaining a safer contraceptive, not losing her preferred one.

Example Opening

Strong opening: "Hello Ruth, I can see you've had quite a week with the A&E visit and the migraine. I completely understand your frustration about the pill being stopped. Let me explain what's going on and then we'll find you a really good alternative."

When explaining the risk: "The reason this matters is about stroke risk. The combined pill slightly increases your chance of a stroke. Migraine with aura also increases it. When you put both together, especially at 41, the combined risk becomes too high to ignore. It's a bit like two separate speed bumps — each one on its own is manageable, but together they create a real jolt."

Avoid: "A&E was right to stop it — you should never have been on it with migraine." (Undermines previous care and increases anxiety).

How This Appears in the SCA

UKMEC criteria application is a core SCA skill. This case tests whether you can apply a contraindication correctly under pressure from a frustrated patient, explain the clinical reasoning in accessible terms, and present alternative options enthusiastically. Examiners value accurate UKMEC knowledge combined with strong communication skills.

Key Statistic

Combined hormonal contraception increases ischaemic stroke risk 2-4 fold. Migraine with aura independently doubles ischaemic stroke risk. The combined effect is multiplicative, making CHC an absolute contraindication (UKMEC Category 4) for any woman who has ever experienced migraine with aura.

Relevant Guidelines

• UKMEC (UK Medical Eligibility Criteria for Contraceptive Use)
• NICE CG150: Headaches in over 12s — diagnosis and management
• FSRH (Faculty of Sexual and Reproductive Healthcare) guideline on combined hormonal contraception.

Frequently Asked Questions

What is UKMEC Category 4 and why does it matter for the SCA?

UKMEC Category 4 means an unacceptable health risk — the condition is an absolute contraindication to the method. Migraine with aura is UKMEC 4 for all combined hormonal contraception (pill, patch, ring). This is permanent — even a single episode of migraine with aura means CHC cannot be used again. Knowing UKMEC categories is essential SCA knowledge for any contraception-related case.

What is the difference between migraine with and without aura for UKMEC?

Migraine with aura (visual disturbance, sensory or speech symptoms preceding the headache) is UKMEC 4 for CHC — absolute contraindication. Migraine without aura is UKMEC 2 for CHC in women under 35 (advantages generally outweigh risks) and UKMEC 3 in women 35+ (risks generally outweigh advantages). This distinction is clinically critical and frequently tested.

Which contraceptive methods are safe with migraine with aura?

All progestogen-only methods are UKMEC 1 (no restriction): desogestrel POP, hormonal IUS (Mirena), progestogen-only implant (Nexplanon), and progestogen-only injectable (Depo-Provera). The copper IUD is also UKMEC 1. Present these as positive options with their own advantages, not as consolation prizes for losing the combined pill.

Is this contraindication permanent even after just one episode of migraine with aura?

Yes — and this is a common point of confusion for both patients and trainees. A single episode of migraine with aura establishes the contraindication permanently. The underlying vascular vulnerability does not resolve. Even if the patient never experiences another aura, the risk profile has been identified and CHC remains UKMEC 4. A trainee who suggests reviewing the decision if no further migraines occur is clinically incorrect.

How do I present alternative contraception enthusiastically?

Frame alternatives as upgrades, not downgrades. "The Mirena IUS actually gives you lighter periods as a bonus — most women love it once it's settled in." Or "The desogestrel pill is taken every day with no breaks, no periods for many women, and no increased stroke risk." Enthusiasm is contagious — if you present alternatives positively, the patient is more likely to engage with them. A flat, reluctant presentation of options scores poorly.